World Congress 2021

The Promises and Realities of Cellular Therapy: Are We Ready for the Revolution?

We are witnessing numerous innovative cell therapies progress from the laboratory to the clinic every day. This notable event will provide you information on how to address common challenges, gain insight on key strategies, and build upon the successes of others to bring your cell therapy from a potential to a reality.

Watch the videos

World Congress logo

Peter Marks

Keynote Address: FDA's Efforts to Facilitate the Development of the Next Generation of CAR-T Cells

Dr. Peter Marks, Director, Center for Biologics Evaluations & Research, FDA

The first wave of CAR-T cell therapies was not an easy slam dunk. The companies involved met many challenges in transitioning their products from pilot to commercial scale manufacturing, as well as in the clinical development of these drugs. No doubt there were will be future challenges, but I am confident we will meet them.

 

 

Opening Remarks
James C. Foster, Chairman, President & Chief Executive Officer
Charles River Laboratories

FDA's Efforts to Facilitate the Development of the Next Generation of CAR-T Cells
Dr. Peter Marks, Director, Center for Biologics Evaluations & Research, FDA

Cell Therapies: Present & Future State
(Moderator) John Ho, Sr. Vice President Corporate Strategy & Chief Strategy Officer Charles River Laboratories
Chad Cowan, Founder & CEO, Clade Therapeutics
Benjamin Fryer, Founder & Chief Executive Officer Pluristyx
Sadik Kassim, Chief Technology Officer VOR
Ananya Zutshi, Entrepreneur-In-Residence, Immuno-Oncology Cellino

Where You Think You're Going Is Never Where You End Up: A Successful Cell Therapy Story
Maria Cho, VP Business Development & Corporate Strategy Dendreon
Nadeem Sheikh, Vice President Research & Manufacturing Science Dendreon
Mary Parker, Senior Science Writer, Charles River Laboratories

Manufacturability: A Key to Success
(Moderator) Matthew Hewitt, Sr. Director, Scientific Solutions & Cell Gene Therapy, Charles River Laboratories
Matthew Durdy, Chief Executive Officer, Cell & Gene Therapy Catapult Cell & Gene Therapy Catapult
Steven Feldman, Director of Manufacturing & Process Development, Stanford Center for Cancer Cell Therapy
David Sourdive, Co-founder, Executive Vice President Cellectis
Claudia Zylberberg, Founder & Executive Chair Akron Bio

A Conversation Between Two Car-T Pioneers: Researcher and Patient
David Sourdive, Co-founder, Executive Vice President Cellectis
Matthew Moon, Patient, UCART Therapy
Mary Parker, Senior Science Writer, Charles River Laboratories

Closing Remarks
James C. Foster, Chairman, President & Chief Executive Officer
Charles River Laboratories

We are equipped to help you navigate challenges along your cell therapy journey.

Begin Your Journey

Maria Cho Headshot

 

Maria Cho
VP Business Development & Corporate Strategy
Dendreon

 


Chad Cowan Headshot

 

Chad Cowan
Founder & CEO
Clade Therapeutics

 


Matthew Durdy Headshot

 

Matthew Durdy
Chief Executive Officer
Cell & Gene Therapy Catapult

 


Steven Feldman Headshot

 

Steven Feldman
Director of Manufacturing & Process Development
Stanford Center for Cancer Cell Therapy

 


Benjamin Fryer Headshot

 

Benjamin Fryer
Founder & Chief Executive Officer
Pluristyx

 


Sadik Kassim Headshot

 

Sadik Kassim
Chief Technology Officer
VOR

 


Peter Marks Headshot

 

Peter Marks
Director, Center for Biologics Evaluations & Research
FDA

 


Mathew Moon Headshot

 

Mathew Moon
Patient
UCART Therapy

 


Nadeem Sheikh Headshot

 

Nadeem Sheikh
Vice President Research & Manufacturing Science
Dendreon

 


David Sourdive Headshot

 

David Sourdive
Co-founder, Executive Vice President
Cellectis

 


Ananya Zutshi Headshot

 

Ananya Zutshi
Entrepreneur-In-Residence, Immuno-Oncology
Cellino

 


Claudia Zylberberg Headshot

 

Claudia Zylberberg
Founder & Executive Chair
Akron Bio

 


James Foster Headshot

 

James C. Foster
Chairman, President & Chief Executive Officer
Charles River Laboratories

 


John Ho Headshot

 

John Ho
Sr. Vice President Corporate Strategy & Chief Strategy Officer
Charles River Laboratories

 


Matthew Hewitt Headshot

 

Matthew Hewitt
Sr. Director, Scientific Solutions & Cell Gene Therapy
Charles River Laboratories

 


Mary Parker Headshot

 

Mary Parker
Senior Science Writer
Charles River Laboratories